• Sekretariat
  
• Lebenslauf
• Gutachtertätigkeit
• Auszeichnungen
• Mitgliedschaften
• Publikationen

Das Sekretariat ist von Montag bis Freitag von 08.00 Uhr bis 14.00 Uhr telefonisch erreichbar.

Sprechstunden nur nach telefonischer Vereinbarung.

Tel.: 06131 17-7293

für verschiedene Fachzeitschriften (Circulation, Stroke, Circulation Research, European Heart Journal, American Heart Journal, American Journal of Cardiology, Atherosclerosis, Clinical Research in Cardiology, VASA)
Gutachterin im Prüfungs-Kontrollausschuss für den Zweiten Abschnitt der ärztlichen Prüfung des impp (Institut für medizinische und pharmazeutische Prüfungsfragen)

- Werner-Forssmann Poster-Preis, Dresdner Symposium Invasive Kardiologie 1998 und 2000

- Young Investigators Avard, Bereich Angiologie der Dt. Gesellschaft für Innere Medizin 2002

- Dagmar-Eißner-Preis für Nachwuchswissenschaftlerinnen der Johannes Gutenberg-Universität Mainz 2002

- Lehrpreis des Landes Rheinland-Pfalz 2007

- Schwarz Monheim Preis der Deutschen Gesellschaft für Angiologie 2008

Fachgesellschaften

• Dt. Ges. für Angiologie (DGA)
    Mitglied im Beirat der DGA
    Mitglied Kommission Forschung und Lehre
    Delegierte der AWMF
• Dt. Ges. für Kardiologie (DGK)
    Nukleusmitglied der Arbeitsgruppe Angiologie
• Dt. Ges. für Innere Medizin (DGIM)
    Mitglied Kommission für Wissenschaft und Nachwuchsförderung
• Dt. Ges. für Ultraschall in der Medizin (DGUM)
    Mitglied in der Arbeitsgruppe Vaskulärer Ultraschall
• European Society of Cardiology (ESC)
    Mitglied der Working Group on Peripheral Circulation
• Dt. Ges. für Atheroskleroseforschung

Universitätsmedizin Mainz

• Mitglied im Ausschuss für die Lehre
• Mitglied im Fachbereichsrat
• Mitglied im „Edith Heischkel-Programm“ Mentoring in der Medizin

1. Espinola-Klein C., Weisser G., Jagodzinski A., Savvidis S., Warnholtz A., Ostad M.,  Gori T., Munzel T.
   Beta Blockers in Patients with Intermittent Claudication and Arterial Hypertension: Results from the Nebivolol or Metoprolol in Arterial Occlusive Disease (NORMA) Trial
   Hypertension 2011, in press
2. Espinola-Klein C., Weisser G.
   Neue orale Antikoagulanzien zur Therapie der venösen Thromboembolie.
   DMW 2011, in press. Review
3. Peripheral arterial disease.
   Espinola-Klein C.
   Internist (Berl). 2011 May;52(5):549-561. Review
4. Sinning C., Wild P.S., Ojeda Echevarria F.M., Wilde S., Schnabel R., Lubos E., Herkenhoff S., Bickel C., Klimpe S, Gori T., Munzel T.F., Blankenberg S., Espinola-Klein C. for the Gutenberg-Heart Study.
   Sex Differences in Early Carotid Atherosclerosis (From the Community-Based Gutenberg-Heart Study).
   Am J Cardiol 2011, Apr 7 [Epub ahead of print]
5. Espinola-Klein C., Gori T., Münzel T.
   Inflammatory markers and cardiovaskular risk in the metabolic syndrome
   Front Biosci,  2011 Jan 1;16:1663-74. Review
6. Espinola-Klein C., Neufang A., Düber C.
   Infrarenales Aortenaneurysma. Die stille Gefahr
   Der Chirurg BDC 2010; 6: 326-330. Review
7. Espinola-Klein C., Münzel T.
   Risikofaktoren der Atherosklerose: Besonderheiten bei Frauen.
   Ärzteblatt RLP 2010, 63: 19-21. Review. 
8. Espinola-Klein C., Savvidis S.
   Peripheral arterial disease: epidemiology, symptoms and diagnosis.
   Internist 2009; 50: 919-926. Review.
9. Khaw A.V., von Bardeleben R.S., Strasser C., Mohr-Kahaly S., Blankenberg S., Espinola-Klein C., Münzel T.F., Schnabel R
   Direct measurement of left ventricular outflow tract by transthoracic real-time 3D-echocardiography increases accuracy in assessment of aortic valve stenosis.
   Int J Cardiol 2009; 136: 64-71.
10. Espinola-Klein C., Rupprecht H.J., Bickel C., Lackner K., Savvidis S., Messow C.M., Munzel T., Blankenberg S.
    Different calculations of ankle brachial index and their impact on cardiovascular risk prediction.
    Circulation 2008; 118: 961-967.
11. Espinola-Klein C., Rupprecht H.J., Bickel C., Lackner K., Genth-Zotz S., Post F., Munzel T., Blankenberg S.
    Impact of inflammatory markers on cardiovascular mortality in patients with metabolic syndrome.
    Eur J Cardiovasc Prev Rehabil; 2008; 15: 278-284.
12. Espinola-Klein C., Neufang A., Düber C.
    Infrarenal aortic aneurysm.
    Internist 2008; 49: 955-964. Review.
13. Espinola-Klein C., Münzel T.
    Oxidativer Stress und Endothelfunktion: Welche Rolle hat das Geschlecht?
    Im Blickpunkt der Mann 2008, 6: 29-31. Review.
14. Neufang A., Espinola-Klein C., Dorweiler B., Pitton M., Savvidis S., Schmiedt W., Vahl C.F.
    Questionable value of adjuvant arteriovenous fistula in pedal bypass at high risk for early failure.
    Ann Vasc Surg 2008 22: 379-387.
15. Schnabel R., Messow C.M., Lubos E., Espinola-Klein C., Rupprecht H.J., Bickel C., Sinning C., Tzikas S., Keller T., Genth-Zotz S., Lackner K.J., Münzel T.F., Blankenberg S.
    Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study.
    Eur Heart J 2008; 29: 649-657.
16. Espinola-Klein C., Rupprecht H.J., Bickel C., Lackner K., Schnabel R., Munzel T., Blankenberg S.
    Inflammation, atherosclerotic burden and cardiovascular prognosis.
    Atherosclerosis 2007; 195: 126-134.
17. Espinola-Klein C., Rupprecht H.J., Bickel C., Post F., Genth-Zotz S., Lackner K., Munzel T., Blankenberg S.
    Impact of the metabolic syndrome on atherosclerotic burden and cardiovascular prognosis.
    Am J Cardiol; 2007; 99: 1623-1628.
18. Espinola-Klein C., Rupprecht H.J., Bickel C., Schnabel R., Genth-Zotz S., Torzewski M., Lackner K., Munzel T., Blankenberg S.
    Glutathione peroxidase 1 activity, atherosclerotic burden and prognosis.
    Am J Cardiol; 2007; 99: 808-812.
19. Neufang A., Espinola-Klein C., Dorweiler B., Savvidis S., Messow C.M., Schmied W., Vahl C.F.
    Femoropopliteal prosthetic bypass with glutaraldehyde stabilized human umbilical vein (HUV).
    J Vasc Surg. 2007; 46: 280-288.
20. Neufang A., Espinola-Klein C., Dorweiler B., Savvidis S., Schmied W., Vahl C.F.
    Infrapopliteal Composite Bypass with Autologous Vein and Second Generation Glutaraldehyde Stabilized Human Umbilical Vein (HUV) for Critical Lower Limb Ischaemia.
    Eur J Vasc Endovasc Surg. 2007; 34: 583-589.
21. Lubos E., Messow C.M., Schnabel R., Rupprecht H.J., Espinola-Klein C., Bickel C., Peetz D., Post F., Lackner K., Tiret L., Münzel T., Blankenberg S.
    Resistin, acute coronary syndrome and prognosis.
    Atherosclerosis. 2007; 193: 121-128.
22. Regitz-Zagrosek V., Espinola-Klein C.
    Schlagen Frauenherzen anders?
    Kardiologie Up2date 2006 Band 2, Heft 3, Seite 255-260. Review.
23. Sinning J.M., Bickel C., Messow C.M., Schnabel R., Lubos E., Rupprecht H.J., Espinola-Klein C., Lackner K.J., Tiret L., Munzel T., Blankenberg S.
    Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris.
    Eur Heart J. 2006; 27:2962-2968.
24. Schnabel R., Lubos E., Rupprecht H.J., Espinola-Klein C., Bickel C., Lackner K.J., Cambien F., Tiret L., Munzel T., Blankenberg S.
    B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina.
    J Am Coll Cardiol 2006, 47: 552-558.
25. Espinola-Klein C., Blankenberg S., Munzel T.
    Is heme oxygenase-1 a causal player for plaque stability?
    Stroke 2005; 36: 1901-1903. Editorial.
26. Tiret L., Godefroy T., Lubos E., Nicaud V., Tregouet D.-A., Barbaux S., Schnabel R., Bickel C., Espinola-Klein C., Poirier O., Perret C., Munzel T., Rupprecht H.-J., Lackner K., Cambien F., Blankenberg S.
    Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease.
    Circulation 2005, 112: 643-650. 
27. Schnabel R., Blankenberg S., Lubos E., Lackner K.J., Rupprecht H.-J., Espinola-Klein C., Jachmann N., Post F., Peetz D., Bickel C., Cambien F., Tiret L., Munzel T.
    Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease.
    Circ Res 2005; 97: e53-59.
28. Neufang A., Espinola-Klein C., Dorweiler B., Reinstadler J., Pitton M., Savvidis S., Fischer R., Vahl C., Schmiedt W.
    Sequential femorodistal composite bypass with second gene-ration glutaraldehyde stabilized Human Umbilical Vein (HUV).
    Eur J Vasc Endovasc Surg 2005, 30: 176-183. 
29. Schnabel R., Lackner K.J., Rupprecht H.J., Espinola-Klein C., Torzewski M., Lubos E., Bickel C., Cambien F., Tiret L., Munzel T., Blankenberg S.
    Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: Results from the atherogene study.
    J Am Coll Cardiol 2005; 45: 1631-1637. 
30. Espinola-Klein C., Rupprecht H.J., Blankenberg S., Bickel C., Fossmeyer U., Kopp H., Victor A., Peetz D., Lackner K.
    Influence of impaired fasting glucose on the incidence and prognosis of atherosclerosis in various vascular regions.
    Z Kardiol 2004; 93: 48-55
31. Espinola-Klein C., Rupprecht H.-J., Meyer J.
    Carotid stenoisis concomitant to coronary artery disease.
    Chirurg 2004, 75: 667-671.
32. Schlitt A., Heine G., Blankenberg S., Espinola-Klein C., Dopheide J., Bickel C., Lackner K.J., Iz M., Meyer J., Darius H., Rupprecht H.J.
    CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-α levels.
    Thromb Haemostasis 2004, 92: 419-424. 
33. Ninio E., Tregouet D., Carrier J.-L., Stengel D., Bickel C., Perret C., Rupprecht H.-J., Cambien F., Blankenberg S., Tiret L., Espinola-Klein C., Meyer J., Lackner K.J., Hafner G., Tiret L., Poirier O., Godefroy T., Nicaud V., Georges J.-L.
    Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease.
    Hum Molecul Gen 2004, 13: 1341-1351. 
34. Blankenberg S., Tiret L., Bickel C., Schlitt A., Jungmair W., Genth-Zotz S., Lubos E., Espinola-Klein C., Rupprecht H.J.
    Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease.
    Z Kardiol 2004, 93; Suppl 4, 16-23.
35. Rupprecht H.-J., Genth-Zotz S., Jungmair W., Espinola-Klein C., Blankenberg S., Post F.
    Acute coronary syndrome without ST-elevation.
    Z Kardiol 2004, 93 Suppl 4, 1-8. 
36. Tregouet D.A., Barbaux S., Poirier O., Blankenberg S., Bickel C., Escolano S., Rupprecht H.J., Meyer J., Cambien F., Tiret L., Espinola-Klein C., Nicaud V. , George J.-L., Hafner G., Prellwitz W.
    SELPLG gene polymorphisms in relation to plasma SELPLG levels and coronary artery disease.
    Ann Hum Gen 2003, 67: 504-511. 
37. Schmiedt W., Neufang A., Dorweiler B., Espinola-Klein C., Reinstadler J., Kraus O., Herber S., Gerhards  A., Oelert H.
    Short distal origin vein graft in diabetic foot syndrome.
    Zentralbl Chir 2003, 128: 720-725. 
38. Neufang A., Dorweiler B., Espinola-Klein C., Reinstadler J., Kraus O., Schmiedt W., Oelert H.
Limb salvage in diabetic foot syndrome with pedal bypass using the in-situ technique.
Zentralbl Chir 2003, 128: 715-719. 
39. Neufang A., Dorweiler B., Espinola-Klein C., Reinstadler J., Kirsch D., Schmiedt W., Oelert H.
    External reinforcement of varicose veins with PTFE prosthesis in infrainguinal bypass surgery - Clinical results.
    Thorac Cardiovasc Surg 2003, 51: 62-66. 
40. Schmiedt W., Neufang A., Dorweiler B., Reinstadler J., Espinola-Klein C., Savvidis S., Kraus O., Herber S, Gerhards A., Pitton M., Proebstle T.
    Crural and pedal bypass surgery for critical ischemia and nonhealing foot lesions.
    Gefäßchirurgie 2003, 8: 252-258.
41. Espinola-Klein C., Rupprecht H.J., Blankenberg S., Bickel C., Kopp H., Victor A., Hafner G., Prellwitz W., Schlumberger W., Meyer J.
    Impact of infectious burden on progression of carotid atherosclerosis.
Stroke 2002; 33: 2581-2586.
42. Espinola-Klein C., Rupprecht H.J., Blankenberg S., Bickel C., Kopp H., Victor A., Hafner G., Prellwitz W., Schlumberger W., Meyer J.
    Impact of infectious burden on extent and long-term prognosis of atherosclerosis.
    Circulation 2002; 105: 15-21
43. Espinola-Klein C., Rupprecht H.-J., Blankenberg S., Bickel C., Peth S., Kopp H., Victor A., Haffner G., Meyer J.
    Manifestationen der Atherosklerose in verschiedenen Gefäßprovinzen: Gemeinsamkeiten und Unterschiede in Epidemiologie, Pathogenese und Prognose.
    Med Klinik 2002, 97: 221-228
44. Proebstle T.M., Kargl A., Espinola-Klein C., Savvidis S., Knop J., Schmiedt W.
    Implantation of a bovine venous-valve xenograft into the common femoral vein of patients with postthrombotic syndrome.
    Phlebologie 2002, 31: 132-136.
45. Schmiedt W., Duber, C., Pitton M., Neufang A., Dorweiler B., Herber S., Reinstadler J., Kirsch D. Eberle B., Espinola-Klein C., Thelen M., Oelert H.
    Endovascular treatment of aneurysms - Long-term results after 7 years.
    Med Klinik 2002, 97: 204-208.
46. Bickel C., Rupprecht H.J., Blankenberg S., Espinola-Klein C., Schlitt A., Rippin G., Hafner G., Treude R., Othmann H., Hofmann K.-P., Meyer J.
    Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease.
    Am J Cardiol 2002; 89: 901-908. 
47. Proebstle T.M., Lehr H.A., Kargl A., Espinola-Klein C., Rother W., Bethge S., Knop J.
    Endovenous treatment of the greater saphenous vein with a 940-nm diode laser: thrombotic occlusion after endoluminal thermal damage by laser-generated steam bubbles.
    J Vasc Surg 2002, 35: 729-736. 
48. Bickel C., Rupprecht H.J., Blankenberg S., Espinola-Klein C., Rippin G., Hafner G., Lotz J., Prellwitz W., Meyer J.
    Influence of HMG-CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion.
    Int J Cardiol 2002; 82: 25-31. 
49. Rupprecht H.-J., Blankenberg S., Meyer J., Espinola-Klein C.
    Modern therapy in acute coronary syndrome.
    Med Klinik 2002, 97: 236-243.
50. Neufang A., Kraus O., Dorweiler B., Espinola-Klein C., Schmiedt W., Oelert H.
    Pedal artery bypass grafting in diabetic foot syndrome: Indication, technique, and outcome.
    Med Klinik 2002, 97: 256-262. 
51. Blankenberg S., Rupprecht H.J., Bickel C., Espinola-Klein C., Rippin G., Hafner G., Ossendorf M., Steinhagen K., Meyer J.
    Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease.
    Circulation 2001, 103: 2915-2921. 
52. Espinola-Klein C., Rupprecht H.J., Erbel R., Nafe B., Brennecke R., Meyer J.
    Ten-year outcome after coronary angioplasty in patients with single-vessel coronary artery disease and comparison with the results of the Coronary Artery Surgery (CASS) Study.
    Am J Cardiol 2000, 85: 321-326. 
53. Espinola-Klein C., Rupprecht H.J., Blankenberg S., Bickel C., Kopp, H., Rippin, G., Hafner, G., Meyer, J.
    Are morphological or functional changes in the carotid artery wall associated with Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, or herpes simplex virus infection?
    Stroke 2000, 31: 2127-2133. 
54. Espinola-Klein C., Rupprecht H.J., Erbel R., Nafe B., Brennecke R., Meyer J.
    Predictors of adverse outcome after coronary angioplasty.
    J Invas Cardiol 1999, 11: 722-728. 
55. Espinola-Klein C., Rupprecht H.J., Erbel R., Nafe B., Brennecke R., Meyer J.
    Impact of restenosis 10 years after coronary angioplasty.
    Eur Heart J, 1998, 1047-1053
56. Rupprecht H.-J., Espinola-Klein C., Erbel R., Nafe B., Brennecke R., Dietz U., Meyer J.
    Impact of routine angiographic follow-up after angioplasty.
    Am Heart J 1998, 136: 613-619. 
57. Espinola-Klein C., Voigtländer T., Rupprecht H.-J., Kopp H., Nafe B., Meyer J.
    Influence of a conventional pressure dressing on arterial and venous blood flow after cardiac catheterization.
    Z Kardiol 1997, 86: 615-621.
58. Espinola-Klein C., Rupprecht H.J., Voigtländer T., Kopp H., Nafe B., Dietz U., Meyer J.
    Comparison of arterial and venous blood flow between patients with pressure dressing or a new hemostatic puncture closure device after cardiac catheterization.
    J Intervent Cardiol 1997, 10: 357-363. 
59. Dietz U., Rupprecht H.-J., Espinola-Klein C., Meyer J.
    Automatic writing of cardiologic reports by a voice recognition system.
    Z Kardiol 1996, 85: 684-688. 
60. Espinola-Klein C., Rupprecht H.J., Trautmann S., Nafe B., Erbel R., Brennecke R., Pop T., Meyer J.
    Ten-year follow-up of balloon dilatation in stable and unstable angina pectoris.
    DMW 1996, 121: 577-582. 
61. Bach R., Espinola-Klein C., Ozbek C., Jung F., Schieffer H.
    Complications after diagnostic cardiac catheterization or balloon dilatation.
    DMW 1993, 118: 1669-1676.